Suppr超能文献

采用新一代测序技术对多发性硬化症欧洲裔美国人 HLA-DRB1*04:01:01 和 HLA-DRB1*15:01:01 Ⅱ类单体型进行解构。

Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.

机构信息

Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA.

Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

出版信息

Mult Scler. 2019 May;25(6):772-782. doi: 10.1177/1352458518770019. Epub 2018 Apr 23.

Abstract

BACKGROUND

The association between HLA-DRB115:01 with multiple sclerosis (MS) susceptibility is well established, but the contribution of the tightly associated HLA-DRB501:01 allele has not yet been completely ascertained. Similarly, the effects of HLA-DRB1*04:01 alleles and haplotypes, defined at the full-gene resolution level with MS risk remains to be elucidated.

OBJECTIVES

To characterize the molecular architecture of class II HLA-DR15 and HLA-DR4 haplotypes associated with MS.

METHODS

Next-generation sequencing was used to determine HLA-DQB1, HLA-DQA1, and HLA-DRB1/4/5 alleles in 1403 unrelated European-American patients and 1425 healthy unrelated controls. Effect sizes of HLA alleles and haplotypes on MS risk were measured by odds ratio (OR) with 95% confidence intervals.

RESULTS

HLA-DRB115:01:01:01SG (OR = 3.20, p < 2.2E-16), HLA-DRB501:01:01 (OR = 2.96, p < 2.2E-16), and HLA-DRB501:01:01v1_STR1 (OR = 8.18, p = 4.3E-05) alleles all occurred at significantly higher frequencies in MS patients compared to controls. The most significant predis-posing haplotypes were HLA-DQB106:02:01~ HLA-DQA101:02:01:01SG~HLA-DRB115:01:01:01SGHLA-DRB501:01:01 and HLA-DQB106:02:01HLA-DQA101:02:01:01SG~HLA-DRB115:01:01:01SGHLA-DRB501:01:01v1_STR1 (OR = 3.19, p < 2.2E-16; OR = 9.30, p = 9.7E-05, respectively). Analyses of the HLA-DRB104 cohort in the absence of HLA-DRB115:01 haplotypes revealed that the HLA-DQB103:01:01:01HLA-DQA103:03:01:01~HLA-DRB104:01:01:01SGHLA-DRB401:03:01:01 haplotype was protective (OR = 0.64, p = 0.028), whereas the HLA-DQB103:02:01HLA-DQA103:01:01~HLA-DRB104:01:01:01SG~HLA-DRB4*01:03:01:01 haplotype was associated with MS susceptibility (OR = 1.66, p = 4.9E-03).

CONCLUSION

HLA-DR15 haplotypes, including genomic variants of HLA-DRB5, and HLA-DR4 haplotypes affect MS risk.

摘要

背景

HLA-DRB115:01 与多发性硬化症(MS)易感性之间的关联已得到充分证实,但与 HLA-DRB501:01 紧密相关的等位基因的贡献尚未完全确定。同样,HLA-DRB1*04:01 等位基因和单体型的影响,在全基因分辨率水平上与 MS 风险相关,仍有待阐明。

目的

阐明与 MS 相关的 II 类 HLA-DR15 和 HLA-DR4 单体型的分子结构。

方法

使用下一代测序技术确定 1403 名无关欧洲裔美国患者和 1425 名健康无关对照的 HLA-DQB1、HLA-DQA1 和 HLA-DRB1/4/5 等位基因。HLA 等位基因和单体型对 MS 风险的影响大小通过比值比(OR)及其 95%置信区间来衡量。

结果

与对照组相比,HLA-DRB115:01:01:01SG(OR=3.20,p<2.2E-16)、HLA-DRB501:01:01(OR=2.96,p<2.2E-16)和 HLA-DRB501:01:01v1_STR1(OR=8.18,p=4.3E-05)等位基因在 MS 患者中均以更高的频率发生。最显著的易感单体型是 HLA-DQB106:02:01HLA-DQA1*01:02:01:01SGHLA-DRB115:01:01:01SG~HLA-DRB501:01:01 和 HLA-DQB106:02:01~HLA-DQA101:02:01:01SGHLA-DRB1*15:01:01:01SGHLA-DRB501:01:01v1_STR1(OR=3.19,p<2.2E-16;OR=9.30,p=9.7E-05)。在没有 HLA-DRB115:01 单体型的情况下对 HLA-DRB104 队列进行分析,结果表明 HLA-DQB103:01:01:01HLA-DQA1*03:03:01:01HLA-DRB104:01:01:01SG~HLA-DRB401:03:01:01 单体型具有保护作用(OR=0.64,p=0.028),而 HLA-DQB103:02:01~HLA-DQA103:01:01HLA-DRB1*04:01:01:01SGHLA-DRB4*01:03:01:01 单体型与 MS 易感性相关(OR=1.66,p=4.9E-03)。

结论

HLA-DR15 单体型,包括 HLA-DRB5 的基因组变异,以及 HLA-DR4 单体型影响 MS 风险。

相似文献

引用本文的文献

4
Analysis: HLA-DRB1 Gene's Variants and Their Clinical Impact.分析:HLA-DRB1 基因的变异及其临床影响。
Cell Transplant. 2023 Jan-Dec;32:9636897231184473. doi: 10.1177/09636897231184473.

本文引用的文献

1
Multiple Sclerosis in Latin Americans: Genetic Aspects.拉丁美洲人的多发性硬化症:遗传学方面
Curr Neurol Neurosci Rep. 2017 Aug;17(8):57. doi: 10.1007/s11910-017-0768-4.
4
The immunogenetics of multiple sclerosis: A comprehensive review.多发性硬化症的免疫遗传学:全面综述。
J Autoimmun. 2015 Nov;64:13-25. doi: 10.1016/j.jaut.2015.06.010. Epub 2015 Jul 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验